Skip to content

Press Release: Clinchoice Looks to Advance Global Safety Operations with LifeSphere MultiVigilance

Miami, FL – January 14th, 2022 – ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announced ClinChoice has enlisted the LifeSphere MultiVigilance solution to manage pharmacovigilance activities worldwide. This partnership marks the leading global-based Clinical Research Organization (CRO) to entrust ArisGlobal’s data management platform with safety processes such as intake, triage, and processing for its sponsors.
With business in US, China, Europe, India, Japan, and Philippines, globalization of safety data is a core need of Clinchoice, who made the move to LifeSphere in search of multiple language requirements, agile response times, and customization capabilities. ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance.

“At ClinChoice, our sponsors value globalization in tandem with efficient, accurate, and rapid solutions. By moving our pharmacovigilance data processes to LifeSphere to support several global markets and languages, we are confident that our sponsors will be able to quickly collect and process data, leading to medical breakthroughs faster and more accurately than ever before,” shares Mr. Ling Zhen, ClinChoice Global Chairman & CEO.
Pat Jenakanandhini, Chief Product Officer at ArisGlobal, adds that, “ClinChoice is an ideal partner in the globalization of pharmacovigilance. ArisGlobal and ClinChoice have both been in the market for several decades with a core focus on advancing therapy development and improving global health. We are honored to provide market-leading technology to assist ClinChoice in this mission and to be on par with their standard of excellence.”

About ArisGlobal
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

About Clinchoice
ClinChoice is a clinical CRO dedicated to offering high-quality one-stop service to biopharmaceutical, Vaccine, Medical Device, Cosmetics, Nutraceuticals, and Consumer Products clients. These services include Clinical Operations, Project Management, Biostatistics, Data Management, Regulatory Affairs, Pharmacovigilance, Device Safety Medial Affairs, Medical

Download ArisGlobal’s 2024 Industry Report   Learn More

Join us at Breakthrough 2024 to explore life sciences transformation through Intelligent Automation

Registration is closed!